Francesco Abate
Overview
Explore the profile of Francesco Abate including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1969
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marturano V, Abate F, Ambrogi V, Califano V, Cerruti P, Pepe G, et al.
Molecules
. 2021 Jun;
26(9).
PMID: 34066573
Herein, smart coatings based on photo-responsive polymer nanocapsules (NC) and deposited by laser evaporation are presented. These systems combine remotely controllable release and high encapsulation efficiency of nanoparticles with the...
2.
Moon C, Reglero C, Cortes J, Quinn S, Alvarez S, Zhao J, et al.
Nat Cancer
. 2021 Apr;
2(1):98-113.
PMID: 33928261
Angioimmunoblastic T cell lymphoma (AITL) and peripheral T cell lymphoma not-otherwise-specified (PTCL, NOS) have poor prognosis and lack driver actionable targets for directed therapies in most cases. Here we identify...
3.
Sapienza M, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, et al.
Haematologica
. 2018 Nov;
104(4):729-737.
PMID: 30381297
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy for which there is still no effective therapy. In order to identify genetic alterations useful for a...
4.
Gong Q, Wang C, Zhang W, Iqbal J, Hu Y, Greiner T, et al.
Sci Rep
. 2017 Sep;
7(1):11301.
PMID: 28900149
T-cell clonality of peripheral T-cell lymphoma (PTCL) is routinely evaluated with a PCR-based method using genomic DNA. However, there are limitations with this approach. The purpose of this study was...
5.
Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N, et al.
Mol Cancer Res
. 2017 May;
15(8):1051-1062.
PMID: 28483946
is the most commonly mutated tumor suppressor gene and its mutation drives tumorigenesis. Using ChIP-seq for p53 in the absence of acute cell stress, we found that wild-type but not...
6.
Abate F, da Silva-Almeida A, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, et al.
Proc Natl Acad Sci U S A
. 2017 Jan;
114(4):764-769.
PMID: 28062691
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of non-Hodgkin lymphomas frequently associated with poor prognosis and for which genetic mechanisms of transformation remain incompletely understood. Using RNA sequencing and...
7.
Oshima K, Khiabanian H, da Silva-Almeida A, Tzoneva G, Abate F, Ambesi-Impiombato A, et al.
Proc Natl Acad Sci U S A
. 2016 Sep;
113(40):11306-11311.
PMID: 27655895
Although multiagent combination chemotherapy is curative in a significant fraction of childhood acute lymphoblastic leukemia (ALL) patients, 20% of cases relapse and most die because of chemorefractory disease. Here we...
8.
Wang J, Cazzato E, Ladewig E, Frattini V, Rosenbloom D, Zairis S, et al.
Nat Genet
. 2016 Jun;
48(7):768-76.
PMID: 27270107
Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from 114 patients. The analysis shows...
9.
Amato T, Abate F, Piccaluga P, Iacono M, Fallerini C, Renieri A, et al.
Am J Clin Pathol
. 2015 Dec;
145(1):116-27.
PMID: 26712879
Objectives: Recent studies using next-generation sequencing (NGS) analysis disclosed the importance of the intrinsic activation of the B-cell receptor (BCR) pathway in the pathogenesis of sporadic Burkitt lymphoma (sBL) due...
10.
Almeida A, Abate F, Khiabanian H, Martinez-Escala E, Guitart J, Tensen C, et al.
Nat Genet
. 2015 Nov;
47(12):1465-70.
PMID: 26551667
Sézary syndrome is a leukemic and aggressive form of cutaneous T cell lymphoma (CTCL) resulting from the malignant transformation of skin-homing central memory CD4(+) T cells. Here we performed whole-exome...